Infinity Bio, Inc.
Megan Coombs currently serves as the Director of Finance at Infinity Bio, Inc., where responsibilities include leading corporate finance functions, financial planning, and oversight of HR operations. Previous roles include Sr. Director of Operations & Service Excellence at OraSure Technologies and Director of Product Office & Transformation at Diversigen, Inc. Megan's experience also encompasses serving as Director of Service Operations at Baylor College of Medicine, where contributions involved managing large-scale operations and establishing organizational metrics. Early career experiences include a position as Customer Service Manager at Eton Bioscience, Inc. Educational qualifications include an MBA in Business Administration and Management from Concordia University Texas and a B.S. in Biology & Human Development from the University of Houston-Downtown.
This person is not in any teams
Infinity Bio, Inc.
Infinity Bio is a Circulating Antibody Repertoire Profiling service company, leveraging a novel technology, MIPSA (Molecular Indexing of Proteins (or Peptides) by Self Assembly) developed by Dr. H. Ben Larman, a pioneer in this field. Our various antigen libraries provide cost effective, comprehensive and quantitative analyses of antibody responses to infections, vaccinations, self-antigens and allergens. Our proprietary method allows for the rapid and flexible content customization. Infinity Bio can design and create customer specific peptide libraries against any target of choice.